|
Exosomal drug formulations
|
1R41CA189517-01
|
$225,000
|
|
GUPTA, RAMESH
|
3P BIOTECHNOLOGIES, INC.
|
|
A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer
|
1R43CA210817-01A1
|
$152,589
|
$152,589
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S2
|
$50,000
|
$50,000
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
1P20CA192976-01
|
$144,556
|
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
Distance Education to Engage Alaskan Community Health Aides in Cancer Control
|
1R25CA186882-01
|
$210,042
|
|
CUEVA, MELANY
|
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
|
|
Integrin Regulation of Cancer Progression Through Alternative mRNA Splicing and Nonsense-Medidated Decay (NMD)
|
5R01CA129637-07
|
$375,250
|
$375,250
|
DIPERSIO, C. MICHAEL
|
ALBANY MEDICAL COLLEGE
|
|
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
|
1R01CA182284-01A1
|
$346,525
|
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$19,500
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$38,610
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$932,164
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting PML for therapy in leukemia-initiating cells
|
5R00CA139009-05
|
$241,530
|
|
ITO, KEISUKE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
1F31CA183493-01A1
|
$47,676
|
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
(PQB4) Age-cancer interplay of genome and epi-genome in human lung
|
5R01CA180126-02
|
$679,887
|
|
VIJG, JAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The B7x pathway in the tumor microenvironment
|
3R01CA175495-01A1S1
|
$59,075
|
$14,769
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
1R01CA216248-01
|
$565,675
|
$565,675
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
MOTILITY AND INVASION
|
5P01CA100324-15
|
$2,028,990
|
$2,028,990
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Signal transduction regulating tumor cell dissemination
|
5R01CA150344-29
|
$396,625
|
$396,625
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
5P30CA013330-45
|
$3,646,138
|
$1,312,610
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The role of tunneling nanotubes as a novel mode of tumor cell-macrophage communication
|
5F99CA212451-02
|
$44,044
|
$44,044
|
HANNA, SAMER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Roles of formins in breast cancer invasion
|
5R21CA205262-02
|
$217,935
|
$217,935
|
HODGSON, LOUIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-18
|
$417,500
|
$137,775
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The Metastatic Cascade: Macrophages Lead the Way
|
5R01CA172451-06
|
$439,400
|
$145,002
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
|
1R01CA218429-01
|
$1,513,571
|
$1,513,571
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-05
|
$346,525
|
$69,305
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
$12,524
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
The Impact of a Targeted CRC Screening Intervention among Latinos in Central PA
|
5K01CA151752-04
|
$137,943
|
|
DOMINIC, ORALIA
|
ALLEGHENY-SINGER RESEARCH INSTITUTE
|
|
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
|
2R44CA183362-02A1
|
$822,075
|
$411,038
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays
|
2R44CA161965-03
|
$499,745
|
|
LIM, MARK
|
AMBERGEN, INC
|
|
Seventh AACR Conference on The Science of Health Disparities in Racial/Ethnic Min
|
1R13CA192732-01
|
$74,000
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Nicotine Deprivation and Implicit Motivational Processes of Drinking and Smoking
|
3R03CA175870-01A1S1
|
$40,302
|
|
COHN, AMY
|
AMERICAN LEGACY FOUNDATION
|
|
Real-Time Patterns of Smoking and Alcohol Use: A Daily Data Analysis
|
5R03CA175870-02
|
$117,817
|
|
COHN, AMY
|
AMERICAN LEGACY FOUNDATION
|
|
Social Dynamics of Substance Use in Online Social Networks for Smoking Cessation
|
1R01CA192345-01
|
$468,382
|
|
GRAHAM, AMANDA
|
AMERICAN LEGACY FOUNDATION
|
|
Examining Social Influences on Young Adult Smoking and Cessation Trajectories
|
1R03CA187756-01
|
$73,842
|
|
VILLANTI, ANDREA
|
AMERICAN LEGACY FOUNDATION
|
|
Development of breakthrough intra-operative detector and imaging system for parat
|
9R42CA192243-02A1
|
$591,600
|
|
MAHADEVAN-JANSEN, ANITA
|
ANASYS INSTRUMENTS CORPORATION
|
|
Immunosignatures to Distinguish Breast Cancer Subtypes and Cancer Recurrence
|
1R21CA220150-01
|
$123,600
|
$123,600
|
JOHNSTON, STEPHEN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Novel approaches to study immune responses to post translational modifications for cancer detection
|
5U01CA214201-02
|
$462,286
|
$231,143
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
5R01CA201179-02
|
$650,269
|
$325,135
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
3R01CA182901-03S1
|
$129,167
|
$129,167
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
5R01CA182901-03
|
$597,280
|
$597,280
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Proteasome inhibitors for the treatment of solid tumors
|
1R01CA213223-01A1
|
$381,450
|
$381,450
|
KISSELEV, ALEXEI
|
AUBURN UNIVERSITY AT AUBURN
|
|
Interferon-gamma limits the effectiveness of peptide vaccines for cancer
|
5R01CA157303-06
|
$294,616
|
$73,654
|
CELIS, ESTEBAN
|
AUGUSTA UNIVERSITY
|
|
American Indian mHealth Smoking Dependence study (PQ4)
|
7R01CA170336-03
|
$505,033
|
|
PETEREIT, DANIEL
|
AVERA MCKENNAN
|
|
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
|
7R01CA132115-08
|
$428,056
|
$428,056
|
PESTELL, RICHARD
|
BARUCH S. BLUMBERG INSTITUTE
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-02
|
$1,091,415
|
$360,167
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
$24,308
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Risk Prediction for ER Negative Breast Cancer Recurrence
|
5R01CA172511-05
|
$593,132
|
$593,132
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
|
5R01CA182467-05
|
$328,888
|
$328,888
|
CHENG, CHONGHUI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Sympathetic Activation and RANKL/IL6 in Breast Cancer Bone Metastasis
|
5R01CA168717-05
|
$323,700
|
$323,700
|
ELEFTERIOU, FLORENT
|
BAYLOR COLLEGE OF MEDICINE
|
|
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
|
1U01CA214125-01
|
$1,452,478
|
$1,452,478
|
ELLIS, MATTHEW
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
3R01CA137019-05S1
|
$94,661
|
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
Total relevant funding to Breast for this search: $710,067,258
|